Roche's new, sin­gle-dose flu drug gets the green light at a hard charg­ing FDA, break­ing in­to record-set­ting ter­ri­to­ry

Roche got the first new land­mark drug ap­proval we’ve seen in flu for 20 years — while set­ting a record on new drug ap­provals for the same pe­ri­od.

!func­tion(e,t,n,s){var i=”In­fo­gramEm­beds”,o=e.getEle­ments­By­Tag­Name(t)[0],d=/^http:/.test(e.lo­ca­tion)?”http:”:”https:”;if(/^\/{2}/.test(s)&&(s=d+s),win­dow[i]&&win­dow[i].ini­tial­ized)win­dow[i].process&&win­dow[i].process();else if(!e.getEle­ment­ById(n)){var a=e.cre­ateEle­ment(t);a.async=1,a.id=n,a.src=s,o.par­entN­ode.in­sert­Be­fore(a,o)}}(doc­u­ment,”script”,”in­fo­gram-async”,”https://e.in­fo­gram.com/js/dist/em­bed-loader-min.js”);

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER